- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant TL1A antibody is designed to detect tumor necrosis factor ligand superfamily member 15, also called TL1A or vascular endothelial growth inhibitor. TL1A is primarily secreted by endothelial cells and activated immune cells, where it functions as both a costimulatory molecule and a regulator of vascular growth. Its ability to influence T cell activation and angiogenesis makes it a central subject in studies of inflammation, immunity, and cancer.
TL1A binds to death receptor 3, transmitting signals that enhance T cell proliferation and cytokine secretion. It also modulates endothelial biology, suppressing abnormal vascular expansion while supporting immune mediated vascular regulation. Dysregulation of TL1A expression has been associated with autoimmune disorders such as inflammatory bowel disease, rheumatoid arthritis, and psoriasis, linking it to chronic inflammation.
The Recombinant TL1A antibody clone rVEGI/1283 provides reliable and reproducible recognition of this cytokine. Recombinant manufacturing ensures batch consistency, reducing variability in experimental results. Clone rVEGI/1283 has been applied to studies of immune signaling, angiogenesis inhibition, and autoimmune disease models. Its specificity enables accurate exploration of TL1A mediated processes in health and disease.
Research using clone rVEGI/1283 has clarified how TL1A contributes to T cell regulation, angiogenesis, and vascular pathology. Elevated TL1A levels correlate with severity in chronic inflammatory conditions, while altered signaling affects tumor vascularization. This antibody continues to support investigations into how TL1A can be targeted therapeutically for immune modulation and cancer treatment.
NSJ Bioreagents offers this Recombinant TL1A antibody to support studies of immune biology and vascular regulation. The protein is also referenced as TNFSF15 antibody, VEGI antibody, death receptor 3 ligand antibody, and endothelial derived cytokine antibody, reflecting its multiple names in scientific literature.
Titration of the recombinant TL1A antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A full length human recombinant protein was used as the immunogen for this recombinant TL1A antibody.
Store the recombinant TL1A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.